Vaccination by Inhalation
X-rays of COVID-19 exposed monkeys. The left monkey was treated with FLOVID-20. Under Development, FDA approval required
Treatment for new COVID-19 infections. Administered by inhaler. The mutation threat is growing. FLOVID-20 is designed to treat all known variants. Under Development, FDA Approval Required
The FlowVax Platform
A revolutionary targeted killer T-Cell immune system therapy (immunotherapy) platform validated by extensive animal testing in mice and macaques. Medicines that precisely treat cancer and viral disease with minimal side effects.
Stable Dry Powder
Multiple Delivery Pathways
For Virus – inhalation, intramuscular
For Cancer – intranodal, intramuscular
Quick disease-specific therapy creation. Rapid high-volume production capability.
Flow Pharma is dedicated to immunotherapy innovation.
Our exclusive technology and manufacturing expertise are poised to transform the treatment and prevention of cancer and viral disease.
News & Press